U-Neuron Biomedical Inc (TPEX:6973)

Market Cap	1.57B +26.2%
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	29.55M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	443,274
Open	47.50
Previous Close	47.50
Day's Range	47.50 - 53.60
52-Week Range	31.30 - 56.20
Beta	-0.05
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About U-Neuron Biomedical

U-Neuron Biomedical Inc engages in the research and development of cell therapy technology and products in Taiwan. It develops stem cells for the treatment of stroke with autologous stem cell transplantation. The company was founded in 2015 and is based in New Taipei City, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2015
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6973

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 15, 2026

Data Sources Report a data error